Need for additional capital
The company states it will require substantial future capital to fund development and commercialization.
- Scope
- Operating runway and product development
- Materiality
- high
Sintx Technologies, Inc.
SINTX Technologies is a U.S.-based advanced ceramics company focused on silicon nitride materials and components for biomedical and other technical applications. Its business combines materials research, manufacturing, and commercialization of ceramic products used in medical devices, with additional activity in coatings, aerospace-related materials, toll processing, and government-funded work.
−1 021,8 %
45,3 %
−1 018,1 %
−64,7 %
1.51
1.29
| % | |
|---|---|
| Biomedical silicon nitride products | 45% Medical-grade ceramic materials and components used in implant and device applications. |
| Aerospace coatings and materials | 20% Advanced ceramic coatings, materials, and related components for aerospace uses. |
| Toll processing and manufacturing services | 20% Contract processing and manufacturing work performed for third-party customers. |
| Government contracts and grants | 15% Revenue tied to government-funded research, development, and contract work. |
SINTX sells to medical device customers, industrial and aerospace customers, and government counterparties that fund...
- Medical device OEMsprimary
Buy silicon nitride materials and components for implant and fusion-device applications because of biocompatibility and wear properties.
- Aerospace customerssecondary
Buy coatings, materials, and components for technical applications where ceramic performance matters.
- Government agenciessecondary
Fund contract and grant work tied to research, development, and technical programs.
- Third-party manufacturerssecondary
Use toll processing and manufacturing support to access advanced ceramic capabilities without building them in-house.
SINTX is headquartered in the United States and serves customers across multiple regions through its biomedical and...
- •Headquartered and operated from the United States
- •Medical implant use has extended into Europe, South America, and Asia
- •U.S. market is important for medical device and government work
- •International adoption depends on local regulatory and OEM qualification
- •Aerospace and industrial customers may be served through U.S. operations
SINTX’s strategy is to leverage its silicon nitride and advanced ceramics expertise across biomedical, aerospace, and...
01
Commercialize silicon nitride in more device categoriesmedium-term
Broader adoption increases the addressable market for the company’s core material platform.
02
Secure third-party manufacturing and toll processing workshort-term
These relationships can convert technical capability into recurring product and service revenue.
03
Develop non-medical advanced ceramics applicationsmedium-term
Diversification can reduce dependence on a single end market and expand customer reach.
SINTX faces the typical risks of a development-stage materials company, including dependence on customer adoption,...
Commercial adoption risk
Revenue depends on customers qualifying and adopting silicon nitride and related products.
- Scope
- Medical device and aerospace sales
- Materiality
- high
Regulatory and clinical validation risk
Biomedical products must clear technical, clinical, and regulatory hurdles before broad use.
- Scope
- Implant and fusion-device applications
- Materiality
- high
Revenue concentration and volatility
Grant and contract revenue can fluctuate materially with award timing and project disposition.
- Scope
- Government-funded work and contract revenue
- Materiality
- medium
Revenue recognition timing
Quarterly revenue comparability
Grant and contract revenue
Revenue volatility
Derivative liabilities
Net income volatility
Asset impairment and collectability
Balance sheet and earnings estimates
: 29.4.2026